Renal replacement therapy registries-time for a structured data quality evaluation programme

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2215-2220

  Couchoud, Cécile ^a   Lassalle, Mathilde ^a   Cornet, Ronald ^b   Jager, Kitty J ^b  

^a AGENCE DE LA BIOMÉDECINE   (France)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Completeness; Data quality; Quality assessment; RRT registry; Timeliness; Validity

Indexed keywords

CLINICAL PRACTICE; COMPARATIVE STUDY; DATA ANALYSIS; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; INCIDENCE; KIDNEY FAILURE; PREVALENCE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUALITY CONTROL; QUALITY OF LIFE; QUANTITATIVE STUDY; RENAL REPLACEMENT THERAPY; REVIEW; TOTAL QUALITY MANAGEMENT;

COMPLETENESS; DATA QUALITY; QUALITY ASSESSMENT; RRT REGISTRY; TIMELINESS; VALIDITY;

DATA COLLECTION; HUMANS; KIDNEY FAILURE, CHRONIC; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; REGISTRIES; RENAL REPLACEMENT THERAPY; RESEARCH DESIGN;

EID: 84884513865     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft004     Document Type: Review

References (29)

1. Gliklich RE, Dreyer NA. Registries for evaluating patient outcomes: a user's guide. 2nd edn. Rockville, MD. Agency for Healthcare Research and Quality, AHQR Publication No. 10-EHC049. September 2010
2. Lim TO, Goh A, Lim YN et al. Review article: use of renal registry data for research, health-care planning and quality improvement: what can we learn from registry data in the Asia-Pacific region? Nephrology (Carlton) 2008; 13:745-752
3. Skeet RG. Cancer registration: principles and methods. Quality and quality control. IARC Sci Publ 1991; 95: 101-107
4. Wilensky GR. The policies and politics of creating a comparative clinical effectiveness research center. Health Aff (Millwood) 2009; 28: w719-w729
5. Jager KJ, Stel VS, Wanner C et al. The valuable contribution of observational studies to nephrology. Kidney Int 2007; 72: 671-675
6. van Dijk PC, Jager KJ, Stengel B et al. Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 2005; 67: 1489-1499
7. Toubiana L, Richard JB, Landais P. Geographical information system for end-stage renal disease: SIGNe, an aid to public health decision making. Nephrol Dial Transplant 2005; 20: 273-277
8. Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes-United States and Puerto Rico, 1996-2007. MMWR Morb Mortal Wkly Rep 2010; 59:1361-1366
9. Couchoud C, Kooman J, Finne P et al. From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 2009; 24: 217-224
10. Lindberg M, Prutz KG, Lindberg P et al. Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice. Hemodial Int 2009; 13: 181-188
11. van der Veer SN, Jager KJ, Nache AM et al. Translating knowledge on best practice into improving quality of RRT care: a systematic review of implementation strategies. Kidney Int 2011; 80: 1021-1034
12. Jager KJ, Zoccali C. QUality European STudies (QUEST)-a step forward in the quality of RRT care. Nephrol Dial Transplant 2005; 20: 2005-2006
13. Jager KJ, Zoccali C. Quality of care in end-stage renal disease: the importance of comparing 'apples with apples'. Nephrol Dial Transplant 2008; 23: 1116
14. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods part II. Completeness. Eur J Cancer 2009; 45: 756-764
15. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009; 45: 747-755
16. Couchoud C, Jager KJ, Tomson C et al. Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. Nephrol Dial Transplant 2009; 24: 1267-1274
17. Perneger TV, Whelton PK, Klag MJ et al. Diagnosis of hypertensive end-stage renal disease: effect of patient's race. Am J Epidemiol 1995; 141: 10-15
18. Wiebe S, Guyatt G, Weaver B et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003; 56: 52-60
19. Hofferkamp JE. Standards for completeness, quality, analysis, management, security and confidentiality of data. Standards for Cancer Registries Volume III. Springfield (IL): North American Association of Central Cancer Registries, 2010
20. Thoburn KK, German RR, Lewis M et al. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer 2007; 109: 1607-1616
21. Hommel K, Rasmussen S, Madsen M et al. The Danish Registry on regular dialysis and transplantation: completeness and validity of incident patient registration. Nephrol Dial Transplant 2010; 25: 947-951
22. Completeness and reliability of USRDS data: comparisons with the Michigan Kidney Registry. Am J Kidney Dis 1992; 20:84-88
23. Warsi AA, White S, McCulloch P. Completeness of data entry in three cancer surgery databases. Eur J Surg Oncol 2002; 28: 850-856
24. How good are the data? USRDS data validation special study. Am J Kidney Dis 1992; 20:68-83
25. Nahm ML, Pieper CF, Cunningham MM. Quantifying data quality for clinical trials using electronic data capture. PloS one 2008; 3: 3049
26. Goldberg SI, Niemierko A, Turchin A. Analysis of data errors in clinical research databases. AMIA Annu Symp Proc 2008; 6: 242-246
27. Jager KJ, Zoccali C. Comorbidity data collection by renal registries-a remaining challenge. Nephrol Dial Transplant 2009; 24: 2311-2313
28. Whitney CW, Lind BK, Wahl PW. Quality assurance and quality control in longitudinal studies. Epidemiol Rev 1998; 20: 71-80
29. Arts DG, De Keizer NF, Scheffer GJ. Defining and improving data quality in medical registries: a literature review, case study, and generic framework. J Am Med Inform Assoc 2002; 9: 600-611